Zoepf Thomas, Maldonado-Lopez Evelyn J, Hilgard Philip, Malago Massimo, Broelsch Christoph E, Treichel Ulrich, Gerken Guido
Department of Gastroenterology and Hepatology, University Hospital of Essen, Essen, Germany.
Liver Transpl. 2006 Jan;12(1):88-94. doi: 10.1002/lt.20548.
Biliary strictures after liver transplantation are a therapeutic challenge for endoscopy. Anastomotic strictures occur in 10% of patients after liver transplantation, leading untreated to mortality and ultimately to graft failure. Despite of successful reports, to date, there is no defined endoscopic therapy regimen for these cases. Therefore the aim of this study was to determine the most suitable concept for endoscopic treatment of post-liver transplant anastomotic strictures (PTAS). A total of 72 patients post-liver transplantation, who received endoscopic retrograde cholangiography (ERC) as a consequence of suspected biliary complications were retrospectively screened for the presence of PTAS. In all patients graft rejection or bile duct ischemia were excluded prior to ERC by liver biopsy or Doppler ultrasound respectively. We compared either balloon dilatation (BD) alone or dilatation plus placement of an increasing number of bile duct endoprostheses (BD + endoprostheses) in a retrospective analysis. A total of 25 of 75 patients showed PTAS. Overall, endoscopic therapy was successful in 22 of 25 patients (88%). BD was initially successful in 89% but showed recurrence in 62%. BD + endoprostheses was initially successful in 87%, and recurrence was observed only in 31%. All recurrences were successfully retreated by BD + endoprostheses. During 22 of 109 (20%) treatment sessions stone extraction was necessary. Complication rate was low with bacterial cholangitis in 8 of 109 (7.3%) sessions, mild pancreatitis in 10 of 109 (9%) sessions and minor bleeding in 2 of 25 (8%) sphincterotomies. Median follow-up after conclusion of endoscopic therapy is 6 months (range 1-43). In conclusion, our data confirm that endoscopic therapy of PTAS is highly effective and safe. As primarily successful BD shows a high rate of recurrence, we recommend a combination of BD followed by an increasing number and diameter of endoprostheses. Therapy sessions are effective at short intervals of every 2-3 months.
肝移植术后胆管狭窄是内镜治疗面临的一项挑战。肝移植术后10%的患者会出现吻合口狭窄,若不治疗会导致死亡并最终造成移植肝失功。尽管有成功的报道,但迄今为止,对于这些病例尚无明确的内镜治疗方案。因此,本研究的目的是确定肝移植术后吻合口狭窄(PTAS)最适宜的内镜治疗方案。对72例肝移植术后因怀疑有胆道并发症而接受内镜逆行胆管造影(ERC)的患者进行回顾性筛查,以确定是否存在PTAS。在所有患者中,分别在ERC检查前通过肝活检或多普勒超声排除移植肝排斥反应或胆管缺血。我们在一项回顾性分析中比较了单纯球囊扩张(BD)或扩张加放置数量逐渐增加的胆管内支架(BD + 内支架)两种治疗方法。75例患者中有25例显示存在PTAS。总体而言,25例患者中有22例(88%)内镜治疗成功。BD最初成功率为89%,但复发率为62%。BD + 内支架最初成功率为87%,复发率仅为31%。所有复发患者均通过BD + 内支架成功再次治疗。在109次治疗中有22次(20%)需要进行取石操作。并发症发生率较低,109次治疗中有8次(7.3%)发生细菌性胆管炎,109次治疗中有10次(9%)发生轻度胰腺炎,25次括约肌切开术中2次(8%)发生轻微出血。内镜治疗结束后的中位随访时间为6个月(范围1 - 43个月)。总之,我们的数据证实PTAS的内镜治疗是高效且安全的。由于单纯BD最初虽成功但复发率高,我们建议先进行BD,随后增加内支架数量和直径。每2 - 3个月的短间隔治疗有效。